Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of tocilizumab in systemic sclerosis
2015-000424-28Phase 3Completed
- Sponsor
- Roche
- Start
- Jul 2015
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in systemic sclerosis (SSc) comparing Tocilizumab with Placebo (2 arms). Primary endpoint: Change in modified Rodnan Skin Score at Week 48. Started Jul 2015; status: completed.
02
Drugs
tocilizumab
03
Conditions
systemic sclerosis (SSc)
Beyond the preview
Go deeper on 2015-000424-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-000424-28.